Sequential Evaluation of NT-proBNP in Heart Failure Insights Into Clinical Outcomes and Efficacy of Vericiguat

Overview of attention for article published in JACC: Heart Failure, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source

twitter: 31 X users
guideline: 1 clinical guideline source

Readers on

mendeley: 24 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

vericiguat - Clinical and Pharmacoeconomic combined Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 15 Sep 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.